review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1586/17476348.2015.1068693 |
P698 | PubMed publication ID | 26175269 |
P50 | author | Valentina Fainardi | Q55094096 |
Sejal Saglani | Q42608323 | ||
P2860 | cites work | A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients. | Q53979709 |
Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma. | Q54426683 | ||
Non-eosinophilic cor ticosteroid unresponsive asthma | Q55094026 | ||
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma | Q57892223 | ||
In utero cigarette smoke exposure impairs somatic and lung growth in BALB/c mice | Q58385196 | ||
Fungal allergy in asthma-state of the art and research needs | Q22001138 | ||
Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations | Q24307696 | ||
Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice | Q24600284 | ||
Asthma across the ages: knowledge gaps in childhood asthma | Q26821787 | ||
The genomic origins of asthma | Q27013204 | ||
Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program | Q30428546 | ||
The molecular phenotype of severe asthma in children. | Q30432832 | ||
Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells | Q33508406 | ||
Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data | Q33685280 | ||
Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations | Q33720547 | ||
Spirometric lung function in school-age children: effect of intrauterine growth retardation and catch-up growth. | Q33821411 | ||
In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma. | Q34120964 | ||
Lebrikizumab treatment in adults with asthma | Q34205683 | ||
IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma | Q34446514 | ||
Age-of-asthma onset as a determinant of different asthma phenotypes in adults: a systematic review and meta-analysis of the literature. | Q34458002 | ||
Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation | Q34566553 | ||
Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation | Q34580221 | ||
Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma | Q34987105 | ||
Parental smoking and lung function in children: an international study. | Q53259997 | ||
Fungal sensitization in childhood persistent asthma is associated with disease severity. | Q53341453 | ||
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. | Q34987195 | ||
Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults | Q35023114 | ||
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis | Q35081904 | ||
Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells | Q35142836 | ||
Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 | ||
Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease | Q35180759 | ||
Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation | Q35190104 | ||
Type 2 inflammation in asthma--present in most, absent in many | Q35322784 | ||
The importance of bacterial and viral infections associated with adult asthma exacerbations in clinical practice | Q35527327 | ||
The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development | Q35599871 | ||
Association of improved air quality with lung development in children | Q35603158 | ||
Early identification of atopy in the prediction of persistent asthma in children | Q35633553 | ||
Noninvasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma | Q35672591 | ||
Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life | Q35813698 | ||
Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma | Q35855205 | ||
Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology | Q36044280 | ||
Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines | Q36054219 | ||
Genome-wide association study of the age of onset of childhood asthma | Q36069551 | ||
Early growth and adult respiratory function in men and women followed from the fetal period to adulthood | Q36225633 | ||
Management of severe asthma in children | Q36316775 | ||
Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma | Q36316780 | ||
Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma | Q36316785 | ||
Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood | Q36371040 | ||
The link between fungi and severe asthma: a summary of the evidence. | Q36409578 | ||
Airway smooth muscle in bronchial tone, inflammation, and remodeling: basic knowledge to clinical relevance | Q36414879 | ||
Specific patterns of allergic sensitization in early childhood and asthma & rhinitis risk. | Q36570245 | ||
Controversies in the management of preschool viral wheeze | Q36650937 | ||
Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children | Q36915476 | ||
Body mass and glucocorticoid response in asthma. | Q36915488 | ||
Chronic exposure to ambient levels of urban particles affects mouse lung development | Q36915499 | ||
Severe asthma: an expanding and mounting clinical challenge | Q36935177 | ||
Rhinovirus wheezing illness and genetic risk of childhood-onset asthma | Q37128812 | ||
The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma | Q37244199 | ||
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing | Q37365524 | ||
The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation | Q37524704 | ||
Passive smoking impairs histone deacetylase-2 in children with severe asthma. | Q37553296 | ||
Linkage between smoking and asthma | Q37615478 | ||
Clinical heterogeneity in the severe asthma research program | Q37651783 | ||
Environmental exposures and asthma morbidity in children living in urban neighborhoods | Q37697764 | ||
Cluster analysis and clinical asthma phenotypes. | Q37711387 | ||
WHO universal definition of severe asthma | Q37837401 | ||
Pulmonary immunity during respiratory infections in early life and the development of severe asthma | Q37842564 | ||
Neonatal chlamydial pneumonia induces altered respiratory structure and function lasting into adult life. | Q37850554 | ||
Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology | Q37853685 | ||
Maternal and fetal origins of lung disease in adulthood | Q37978682 | ||
Asthma phenotypes: the evolution from clinical to molecular approaches | Q38007831 | ||
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma | Q38171268 | ||
Body mass index and the incidence of asthma in children | Q38185540 | ||
Asthma therapy and its effect on airway remodelling. | Q38233318 | ||
Epithelial cytokines and pulmonary allergic inflammation | Q38364242 | ||
Outcomes of childhood asthma to the age of 50 years | Q40218924 | ||
Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. | Q42213596 | ||
Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial | Q42262026 | ||
Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness. | Q42602368 | ||
National Review of Asthma Deaths (NRAD). | Q42975413 | ||
Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples | Q43099470 | ||
Temporal assessment of airway remodeling in severe asthma using quantitative computed tomography. | Q43111808 | ||
Respiratory syncytial virus infection reversed anti-asthma effect of neonatal Bacillus Calmette-Guerin vaccination in BALB/c mice | Q43688145 | ||
Maternal nicotine exposure during gestation and lactation of rats induce microscopic emphysema in the offspring | Q44049875 | ||
Childhood asthma after bacterial colonization of the airway in neonates | Q44570200 | ||
Risk factors of frequent exacerbations in difficult-to-treat asthma | Q44681336 | ||
Eosinophils in the spotlight: Eosinophilic airway inflammation in nonallergic asthma | Q44715380 | ||
Respiratory syncytial virus: a sleeping giant? | Q44816055 | ||
The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production | Q45435028 | ||
Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis | Q45874711 | ||
Maternal smoking during pregnancy induces airway remodelling in mice offspring. | Q46171911 | ||
Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function | Q46303720 | ||
Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children | Q46664259 | ||
Effects of fetal growth restriction on lung development before and after birth: a morphometric analysis. | Q46756474 | ||
Haplotype associated with low interleukin-10 production in patients with severe asthma | Q47808922 | ||
Childhood infections, the developing immune system, and the origins of asthma. | Q47885783 | ||
Mepolizumab treatment in patients with severe eosinophilic asthma | Q48065984 | ||
The association between childhood asthma and adult chronic obstructive pulmonary disease | Q48118694 | ||
Prognostic value of cluster analysis of severe asthma phenotypes. | Q51071213 | ||
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. | Q52930916 | ||
P433 | issue | 4 | |
P921 | main subject | asthma | Q35869 |
P1104 | number of pages | 10 | |
P304 | page(s) | 419-428 | |
P577 | publication date | 2015-07-15 | |
P1433 | published in | Expert Review of Respiratory Medicine | Q15754583 |
P1476 | title | The need to differentiate between adults and children when treating severe asthma | |
P478 | volume | 9 |
Q61963165 | Asthma Endotyping and Biomarkers in Childhood Asthma |
Q39034456 | Asthma phenotypes in children and stratified pharmacological treatment regimens |
Q47863226 | Moving toward consensus on diagnosis and management of severe asthma in children |
Q52593722 | Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Diseases. |